Comparison of tumour and whole body absorbed doses of 177-Lu- DOTA-TATE and Lu-177 DOTA-NOC treatment in the same patient group

被引：0
|
作者：
Yeyin, N. [1 ]
Kabasakal, L. [1 ]
Akyel, R. [1 ]
Ocak, M. [2 ]
Toklu, T. [3 ]
Selcuk, N. [3 ]
Demir, M. [1 ]
Kanmaz, B. [1 ]
机构：
[1] Istanbul Univ, Cerrahpasa Med Fac, Istanbul, Turkey
[2] Istanbul Univ, Fac Pharm, Dept Pharmaceut Technol, Istanbul, Turkey
[3] Yeditepe Univ, Fac Med, Dept Nucl Med, Istanbul, Turkey
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2013年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S200 / S200
页数：1
相关论文
共 50 条
  • [1] First comparative dosimetric results after peptide receptor radionuclide therapy (PRRT) using Lu-177 DOTA-NOC and Lu-177 DOTA-TATE
    Wehrmann, C.
    Senftleben, S.
    Baum, R. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S373 - S373
  • [2] First comparative dosimetric results after peptide receptor radionuclide therapy (PRRT) using Lu-177 DOTA-NOC and Lu-177 DOTA-TATE
    Wehrmann, C.
    Senftleben, S.
    Baum, R. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S179 - S179
  • [3] Results of individual patient dosimetry in peptide receptor radionuclide therapy with 177Lu DOTA-TATE and 177Lu DOTA-NOC
    Wehrmann, Christiane
    Senftleben, Stefan
    Zachert, Carolin
    Mueller, Dirk
    Baum, Richard P.
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2007, 22 (03) : 406 - 416
  • [4] Dosimetry in peptide receptor radionuclide therapy (PRRNT): comparative results using Lu-177 DOTA-TATE, DOTA-NOC und DOTA-TOC
    Schuchardt, C.
    Baum, R. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S244 - S244
  • [5] Individual effective half-life in Lu-177 Dota-Tate therapy
    Fitschen, J.
    Knoop, B. O.
    Knapp, W. H.
    Geworski, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S339 - S339
  • [6] Preliminary Results of Lu-177 DOTA-TATE Therapy in Patients with Neuroendocrine Tumor
    Hekimsoy, T.
    Isgoren, S.
    Gorur, G. Daglioz
    Demir, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S596 - S596
  • [7] Preparation of DOTA-TATE and DOTA-NOC freeze-dried kits for formulation of patient doses of 177Lu-labeled agents and their comparison for peptide receptor radionuclide therapy application
    Das, Tapas
    Bhadwal, Mohini
    Banerjee, Sharmila
    Sarma, H. D.
    Shinto, Ajit
    Kamaleshwaran, K. K.
    JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY, 2014, 299 (03) : 1389 - 1398
  • [8] Preparation of DOTA-TATE and DOTA-NOC freeze-dried kits for formulation of patient doses of 177Lu-labeled agents and their comparison for peptide receptor radionuclide therapy application
    Tapas Das
    Mohini Bhadwal
    Sharmila Banerjee
    H. D. Sarma
    Ajit Shinto
    K. K. Kamaleshwaran
    Journal of Radioanalytical and Nuclear Chemistry, 2014, 299 : 1389 - 1398
  • [9] In house labeling and characterization of 177Lu DOTA-TATE
    Yadav, Alok Kumar
    Meera, V
    Banerjee, Sharmila
    Malhotra, A.
    Bal, Chandarsekhar
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [10] Intraindividual comparison of [177Lu]Lu-DOTA-EB-TATE and [177Lu]Lu-DOTA-TOC
    Heribert Hänscheid
    Philipp E. Hartrampf
    Andreas Schirbel
    Andreas K. Buck
    Constantin Lapa
    European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 2566 - 2572
12345